Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Resilience Measurement, Prediction, and Its Role in Older Adults With Late-Stage Lung Cancer

NCT04825912 is registered in ClinicalTrials.gov with Duke University as lead sponsor.

NCT NCT04825912
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04825912 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Resilience Measurement, Prediction, and Its Role in Older Adults With Late-Stage Lung Cancer
Lead sponsor
Duke University
Phase
Not applicable
Overall status
Completed
Start date
May 3, 2021
Completion date
March 18, 2022
Enrollment
18 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

lung cancer stage iii, lung cancer stage iv